Global General Anesthesia Drugs Market

General anesthesia refers to the state produced when a patient receives medications for amnesia, muscle paralysis,sedation, and analgesia. Anaesthetists, physician assistants or nurse anaesthetists administer these drugs. An anesthetized patient can be thought of as being in a controlled, reversible state of unconsciousness. Anesthesia allows a patient to endure surgical procedures that would otherwise cause intolerable pain, potentiate extreme physiologic exacerbations, and result in unpleasant memories. Drugs given to induce general anaesthesia can be either as gases or vapours (inhalational anaesthetics), or as injections (intravenous anaesthetics or even intramuscular). The various advantages of general anesthesia include the following:

--> Can be used in cases of sensitivity to local anesthetic agent

--> Can be administered without moving the patient from the supine position

--> Allows proper muscle relaxation for prolonged periods of time

--> Facilitates complete control of the airway, breathing, and circulation

Market Dynamics

Growth of the global general anaesthesia drugs market is mainly driven by growing volume of surgical procedures including orthopedic, general surgeries, cardiac, and others. Moreover, growth in healthcare facilities in emerging economies and advancements in the anesthesia drug delivery methods, such as jet injection, inhalation and computer controlled anesthesia delivery systems will further encourage the general anesthesia drugs industry. However, side effects associated with anesthesia drugs such as nausea, vomiting, allergy, and complications during surgical procedures restraint the growth of the market. Further factors which inhibit the growth of the general anesthesia drugs market are lack of skilled anesthesiologist, inadequate insurance coverage and high prices of these drugs.

Market Segmentation

The global general anesthesia drugs market has been segmented on the basis of drugs and route of administration. The various drugs include Sevoflurane, Propofol, Desflurane, isoflurane, Dexmedetomidine, Isoflurane, Midazolam and others. In terms of route of administration, the market is classified into intravenous and inhalational. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of the intravenous market.

Regional/Geographic Analysis

By geography, in the year 2016, North America held the maximum share of general anesthesia drugs market and is further projected to continue its dominance during the forecast period. The continous increase in demand for propofol is one of the primary reason for this dominance. Other prominant markets for anesthesia drugs include Europe, Asia-Pacific, Middle East and Africa, and South America. North America has been subdivided into the USA, Canada, and Mexico. Europe has been subdivided into the UK, Germany, France, Italy, Spain, and Rest of Europe. The Asia-Pacific market has been subdivided into India, China, Japan, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East and Africa market has been subdivided into GCC countries, South Africa and Rest of MENA. The South American market has been subdivided into Brazil, Argentina, and Rest of South America.

Key Players

The global anesthesia drugs market is largely fragmented and competitive due to the presence of a large number of regional and international vendors. Some of the key players in the market are Hospira, Novartis, Johnson & Johnson, GSK, Eisai, Roche, Astra Zeneca, Baxter, Primex Pharmaceuticals, and Abbott among others.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage